Trine Schütt

Trine Schütt

Auto-generated profile, based on publicly available information

Trine Schütt

Department of Veterinary Clinical and Animal Sciences Faculty of Health and Medical Sciences University of Copenhagen Frederiksberg C Denmark

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Closed access
PDF file
RFR. Fast
R. Fast
TST. Schütt
T. Schütt
NTN. Toft
N. Toft
AMA. Møller
A. Møller
MBM. Berendt
M. Berendt

1 November 2015 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
TST. Schütt
T. Schütt
NTN. Toft
N. Toft
MBM. Berendt
M. Berendt
Background: Canine cognitive dysfunction (CCD) is an age-dependent neurodegenerative condition dominated by changes in behavioral patterns. Cohort studies investigating cognitive status in dogs are lacking. Objectives: To investigate cognitive function, progression of age-related behavioral changes, survival, and possible biomarkers of CCD in aged dogs. Animals: Fifty-one dogs >8 years old; 21 with no cognitive deficits, 17 with mild cognitive impairments (MCI) and 13 with CCD. Methods: Longitudinal study. Recruitment period of 12 months and an observational period of 24 months including a baseline and 3 planned subsequent assessments. Cognitive status was determined using validated questionnaires. Plasma Aβ-peptides were quantified using commercial ELISA assays and cytokines by a validated immunoassay. Results: Signs characterizing dogs with CCD were aimless wandering, staring into space, avoid getting patted, difficulty finding dropped food and anxiety. Thirty-three percent of dogs with a normal cognitive status progressed to MCI and 22% classified as MCI progressed to CCD during the study period. For 6 dogs diagnosed with CCD, signs of cognitive dysfunction increased with time. A diagnosis of CCD did not affect survival. The level of plasma Aβ42 was significantly increased (P < .05) in the CCD group (92.8 ± 24.0 pg/mL) compared to the MCI (77.0 ± 12.3 pg/mL) and normal group (74.9 ± 10.0 pg/mL), but no significant differences in concentrations of systemic inflammatory markers were detected. Conclusions: Canine cognitive dysfunction is a progressive disorder with an individual variability in the rate of cognitive decline and clinical signs. Plasma Aβ42 seems to be an interesting plasma biomarker of CCD.

1 November 2015 in Journal of Veterinary Behavior
Verified
Journal Article
Closed access
TSTrine Schütt
Trine Schütt
NTNils Toft
Nils Toft
MBMette Berendt
Mette Berendt

1 January 2003 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
HPHenrik D. Pedersen
Henrik D. Pedersen
TSTrine Schütt
Trine Schütt
RSRikke Søndergaard
Rikke Søndergaard
KQKaren Qvortrup
Karen Qvortrup
LOLisbeth Høier Olsen
Lisbeth Høier Olsen
AKAnnemarie T. Kristensen
Annemarie T. Kristensen